Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,362,755

« Back to Dashboard

Summary for Patent: 5,362,755

Title: Method for treating asthma using optically pure (R)-albuterol
Abstract:The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with chronic administration of racemic albuterol.
Inventor(s): Barberich; Timothy J. (Concord, MA), Young; James W. (Still River, MA)
Assignee: Sepracor, Inc. (Marlborough, MA)
Application Number:08/163,581
Patent Claim Types:
see list of patent claims
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 5,362,755

Country Document Number Publication Date Supplementary Protection Certificate SPC Country SPC Expiration
JapanH05503102May 27, 1993
Japan3085705Sep 11, 2000
Austria135908Apr 15, 1996
Greece3020133Aug 31, 1996
Denmark0509036Jul 29, 1996
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn